At Union, we are committed to enhancing patient care and patient safety.

Therefore, all our products undergo safety monitoring and evaluation throughout the drug distribution lifecycle.
 

Union ensures compliance with local regulatory and our partner’s requirements for processing adverse event information.

We handle adverse event reports associated with the use of any product (pharmaceutical, para-pharmaceutical, medical device including contrast media) in the marketed environment whether, licensed by, or distributed by Union, for human use in Lebanon.

Report an Adverse Event (24/7)
Telephone: +961-5-924162
Email: pharmacovigilance@d-union.com